packageRomosozumab

romosozumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Romosozumab is a monoclonal antibody used to treat osteoporosis. It is authorised in the European Union and is an approved medicine, though it is a relatively new bone-disease drug.

Summary written by glm-5.3-flash from Wikidata Q7363297 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:romosozumab
ATC codes:M05BX06
DrugBank:DB11866
Wikidata:Q7363297
molar mass:145805 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown